RUBIN LEO has a total of 18 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1972. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets medical technology, pharmaceuticals and macromolecular chemistry and polymers are INNOVATION TECH INC, SHANGHAI OUBANG MEDICAL MAN CO LTD and MALLINCKRODT PHARMA IP TRADING D A C.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Australia | 1 | |
#6 | Germany | 1 |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Object sterilising | |
#4 | Electrotherapy | |
#5 | Syringes | |
#6 | Diagnosis and surgery | |
#7 | Polysaccharides | |
#8 | Nanostructure applications | |
#9 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Rubin Leo | 18 |
#2 | Mousa Shaker | 6 |
#3 | Bernstein David | 4 |
#4 | Schroeppel Edward A | 1 |
#5 | Mattes Edward | 1 |
#6 | Bonnerup Chris A | 1 |
Publication | Filing date | Title |
---|---|---|
US2017049710A1 | Novel formulations and methods | |
US2016151532A1 | Novel hemostatic patch and uses thereof | |
US2013337053A1 | Novel formulations and methods | |
US2013338072A1 | Methods for treating organs | |
US2011142947A1 | Formulations | |
US2008051882A1 | Medical device for intra-lumenal delivery of pharmaceutical agents | |
AU2003243439A8 | Medical device for intra-lumenal delivery of pharmaceutical agents | |
EP1233811A2 | Methods for treating cardiac arrest or pulmonary hypertension and compositions for use therein comprising vasoactive intestinal polypeptide and cardiac device for electrical and chemical regulation and methods of use | |
DE2260563A1 | DEVICE FOR ELECTRICALLY STIMULATING THE HEART |